Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -31.62%356.13K | -56.20%357.06K | -51.30%345.89K | -21.40%2.51M | -39.11%459.83K | -32.57%520.78K | -3.00%815.19K | -13.45%710.31K | 5.44%3.19M | -14.02%755.16K |
| Operating revenue | -32.05%349.71K | -56.66%350.67K | -51.79%339.51K | -21.58%2.48M | -39.46%453.53K | -32.85%514.63K | -3.02%809.15K | -13.54%704.27K | 6.50%3.16M | -14.11%749.13K |
| Cost of revenue | -24.02%220.13K | -40.77%228.91K | -41.37%239.91K | -27.81%1.35M | -34.76%265.78K | -36.19%289.72K | -27.62%386.47K | -14.07%409.19K | 0.48%1.87M | -21.76%407.37K |
| Gross profit | -41.14%135.99K | -70.11%128.14K | -64.80%105.98K | -12.30%1.15M | -44.20%194.06K | -27.40%231.06K | 39.91%428.73K | -12.58%301.12K | 13.38%1.32M | -2.77%347.8K |
| Operating expense | 20.84%308.63K | -43.50%112.32K | 23.64%367.55K | -19.34%1.12M | -38.05%372.01K | -24.14%255.4K | 11.45%198.79K | 7.19%297.28K | 46.40%1.39M | 62.61%600.47K |
| Selling and administrative expenses | 8.00%263.17K | -61.09%72.94K | 10.29%315.25K | -21.56%973.34K | -47.05%256.36K | -25.00%243.69K | 12.69%187.45K | 7.65%285.85K | 42.36%1.24M | 42.53%484.17K |
| -General and administrative expense | 8.00%263.17K | -61.09%72.94K | 10.29%315.25K | -21.56%973.34K | -47.05%256.36K | -25.00%243.69K | 12.69%187.45K | 7.65%285.85K | 42.36%1.24M | 42.53%484.17K |
| Research and development costs | --33.46K | --27.2K | --39.62K | --69.18K | --69.18K | --0 | --0 | --0 | --0 | ---- |
| Depreciation amortization depletion | 2.41%12K | 7.37%12.18K | 10.92%12.68K | -0.48%47.03K | 7.83%12.54K | -0.60%11.72K | -5.60%11.34K | -3.34%11.43K | -29.24%47.26K | -30.11%11.63K |
| -Depreciation and amortization | 2.41%12K | 7.37%12.18K | 10.92%12.68K | -0.48%47.03K | 7.83%12.54K | -0.60%11.72K | -5.60%11.34K | -3.34%11.43K | -29.24%47.26K | -30.11%11.63K |
| Provision for doubtful accounts | ---- | ---- | ---- | -67.58%33.93K | ---- | ---- | ---- | ---- | 709.36%104.67K | ---- |
| Operating profit | -609.03%-172.64K | -93.12%15.83K | -6,917.02%-261.57K | 141.46%31.47K | 29.57%-177.96K | -32.29%-24.35K | 79.55%229.94K | -94.28%3.84K | -136.12%-75.91K | -2,084.95%-252.67K |
| Net non-operating interest income (expenses) | -32.75%-904 | -128.46%-1.12K | -58.83%-1.39K | 49.62%-3.61K | -26.38%-1.56K | 57.86%-681 | 75.45%-492 | 62.14%-872 | -24.87%-7.16K | 52.97%-1.24K |
| Non-operating interest expense | 32.75%904 | 128.46%1.12K | 58.83%1.39K | -49.62%3.61K | 26.38%1.56K | -57.86%681 | -75.45%492 | -62.14%872 | 24.87%7.16K | -52.97%1.24K |
| Other net income (expenses) | -91.93%5.81K | -95.63%-65.81K | -1,328.73%-34.17K | 92.26%-3.91K | -29.86%-45K | 799.86%71.94K | -9.23%-33.64K | -59.50%2.78K | 77.87%-50.58K | -12.66%-34.65K |
| Gain on sale of security | -91.93%5.81K | -95.63%-65.81K | -1,328.73%-34.17K | 92.26%-3.91K | -29.86%-45K | 799.86%71.94K | -9.23%-33.64K | -59.50%2.78K | 77.87%-50.58K | -12.66%-34.65K |
| Income before tax | -457.53%-167.73K | -126.10%-51.11K | -5,270.99%-297.13K | 117.92%23.95K | 22.19%-224.52K | 490.11%46.92K | 105.55%195.81K | -91.98%5.75K | -453.46%-133.65K | -541.99%-288.55K |
| Income tax | -99.08%55 | 101.77%130 | 0 | 161.74%2.47K | 100.32%24 | -44.73%5.97K | -2.54%-7.36K | 3.83K | -149.09%-3.99K | 68.84%-7.62K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -509.76%-167.79K | -125.22%-51.24K | -15,623.77%-297.13K | 116.57%21.49K | 20.07%-224.54K | 279.42%40.95K | 98.33%203.16K | -97.33%1.91K | -301.61%-129.66K | -1,269.97%-280.94K |
| Net income continuous operations | -509.76%-167.79K | -125.22%-51.24K | -15,623.77%-297.13K | 116.57%21.49K | 20.07%-224.54K | 279.42%40.95K | 98.33%203.16K | -97.33%1.91K | -301.61%-129.66K | -1,269.97%-280.94K |
| Noncontrolling interests | -2,900.00%-672 | 112.94%1.15K | -2,149.21%-1.42K | 55.25%-486 | 50.03%-988 | -98.18%24 | 139.38%541 | 90.37%-63 | -69.95%-1.09K | -4.77%-1.98K |
| Net income attributable to the company | -508.36%-167.12K | -125.85%-52.39K | -15,057.41%-295.71K | 117.09%21.97K | 19.86%-223.55K | 269.52%40.92K | 98.24%202.62K | -97.27%1.98K | -306.29%-128.57K | -1,398.18%-278.96K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -508.36%-167.12K | -125.85%-52.39K | -15,057.41%-295.71K | 117.09%21.97K | 19.86%-223.55K | 269.52%40.92K | 98.24%202.62K | -97.27%1.98K | -306.29%-128.57K | -1,398.18%-278.96K |
| Diluted earnings per share | -504.55%-0.089 | -125.93%-0.0003 | -15,900.00%-0.0016 | 117.39%0.0001 | 20.13%-0.0012 | 17,023.08%0.022 | 100.00%0.0011 | -97.44%0 | -245.00%-0.0007 | -1,254.55%-0.0015 |
| Basic earnings per share | -504.55%-0.089 | -125.93%-0.0003 | -15,900.00%-0.0016 | 117.39%0.0001 | 20.13%-0.0012 | 17,023.08%0.022 | 100.00%0.0011 | -97.44%0 | -245.00%-0.0007 | -1,254.55%-0.0015 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.